Longevity PapersAbout
← All papers
RESEARCH PAPER / 2024-11-25

Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin-STAR frailty interest group.

Namrata Singh, Adam S Faye, Maheen Z Abidi, Shakira J Grant, Clark DuMontier, Anand S Iyer, Nelia Jain, Bharati Kochar, Sarah B Lieber, Rachel Litke, Julia V Loewenthal, Mary Clare Masters, Michael G Nanna, Raele Donetha Robison, Sebastian E Sattui, Anoop Sheshadri, Sandra M Shi, Andrea N Sherman, Jeremy D Walston, Katherine D Wysham, Ariela R Orkaby

Division of Rheumatology, University of Washington, Seattle, WA, USA.Division of Rheumatology, University of Washington, Seattle, WA, USA. · pubmed

Abstract

Frailty is a syndrome that can inform clinical treatments and interventions for older adults. Although implementation of frailty across medical subspecialties has the potential to improve care for the aging population, its uptake has been heterogenous. While frailty assessment is highly integrated into certain medical subspecialties, other subspecialties have only recently begun to consider frailty in the context of patient care. In order to advance the field of frailty-informed care, we aim to detail what is known about frailty within the subspecialties of internal medicine. In doing so, we highlight cross-disciplinary approaches that can enhance our understanding of frailty, focusing on ways to improve the implementation of frailty measures, as well as develop potential interventional strategies to mitigate frailty within these subspecialties. This has important implications for the clinical care of the aging population and can help guide future research.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses frailty as a syndrome that affects older adults and explores its integration into medical specialties, which is relevant to the care of the aging population. However, it primarily focuses on improving clinical treatments and interventions rather than addressing the root causes of aging or lifespan extension. The impact is limited as it presents solid research on implementation strategies but does not introduce significant new findings or breakthroughs in the field of longevity research.

Author of this paper? Send a correction.